首页> Clinical and experimental rheumatology> Tofacitinib inhibits CD4 T cell polarisation to Th1 during priming thereby leading to clinical impact in a model of experimental arthritis

Tofacitinib inhibits CD4 T cell polarisation to Th1 during priming thereby leading to clinical impact in a model of experimental arthritis

导出原文传递

翻译打印收藏纠错

第一作者： Bedaj, M.

作者： Bedaj, M. ^[1] ; Bonilha, C. S. ; McInnes, I. B. ; Garside, P. ; Benson, R. A.

作者单位： University of Glasgow,Univ Glasgow ^[1]

关键词 tofacitinib early rheumatoid arthritis rheumatoid arthritis T cells autoimmunity KINASE INHIBITOR SELF-TOLERANCE BET

发布时间 2023-03-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical and experimental rheumatology

2022年40卷7期

1313-1323页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Clinical and experimental rheumatology

2022年40卷7期

1313-1323页

检索历史清除

Tofacitinib inhibits CD4 T cell polarisation to Th1 during priming thereby leading to clinical impact in a model of experimental arthritis

Clinical and experimental rheumatology

相似文献

同项目论文

Clinical and experimental rheumatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Tofacitinib inhibits CD4 T cell polarisation to Th1 during priming thereby leading to clinical impact in a model of experimental arthritis

Clinical and experimental rheumatology

相似文献

同项目论文

Clinical and experimental rheumatology

相关期刊

检索历史清除